Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women

Hyun-Tae Park, Geum-Joon Cho, Ki Hoon Ahn, Jung-Ho Shin, Soon Cheol Hong, Tak Kim, Jun Young Hur, Young Tae Kim, Kyu Wan Lee, Sun Haeng Kim

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Objectives: The aim of this study was to investigate the relationship between thyroid stimulating hormone (TSH) and metabolic syndrome (MetS) in euthyroid postmenopausal women. Methods: We conducted a cross-sectional study of 2205 Korean postmenopausal women. Subjects who were not euthyroid were excluded. Fasting TSH, free thyroxine (FT4), insulin, glucose, and the level of insulin resistance, estimated by the homeostasis model assessment for insulin resistance (HOMA-IR) were measured. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Results: TSH levels were associated with total cholesterol, LDL-cholesterol, triglycerides and diastolic blood pressure. Using a multiple linear regression analysis, LDL-cholesterol, and triglycerides levels were identified as independently associated with TSH. Multivariate logistic regression analysis determined that TSH levels strongly contributed to MetS. Compared with the lower most quartile (TSH, 0.3-1.44 mIU/L), the adjusted odds ratio for MetS was 1.95 in the upper most quartile (TSH, 2.48-4.00 mIU/L). The prevalence of MetS increased as the TSH quartile showed a gradual increase. Conclusion: We found a close relationship between TSH and MetS in euthyroid postmenopausal women. Therefore, more attention should be focused on postmenopausal women with high normal TSH levels for the management of cardiovascular disease.

Original languageEnglish
Pages (from-to)301-305
Number of pages5
JournalMaturitas
Volume62
Issue number3
DOIs
Publication statusPublished - 2009 Mar 20

Fingerprint

Thyrotropin
Insulin
Regression analysis
LDL Cholesterol
Insulin Resistance
Cholesterol
Regression Analysis
Blood Pressure
Blood pressure
Thyroxine
Linear regression
Logistics
Linear Models
Fasting
Triglycerides
Homeostasis
Cardiovascular Diseases
Cross-Sectional Studies
Education
Logistic Models

Keywords

  • Euthyroid
  • Metabolic syndrome
  • Postmenopause
  • Thyroid stimulating hormone

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. / Park, Hyun-Tae; Cho, Geum-Joon; Ahn, Ki Hoon; Shin, Jung-Ho; Hong, Soon Cheol; Kim, Tak; Hur, Jun Young; Kim, Young Tae; Lee, Kyu Wan; Kim, Sun Haeng.

In: Maturitas, Vol. 62, No. 3, 20.03.2009, p. 301-305.

Research output: Contribution to journalArticle

@article{7dd09815020c4534b2655324be1321bf,
title = "Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women",
abstract = "Objectives: The aim of this study was to investigate the relationship between thyroid stimulating hormone (TSH) and metabolic syndrome (MetS) in euthyroid postmenopausal women. Methods: We conducted a cross-sectional study of 2205 Korean postmenopausal women. Subjects who were not euthyroid were excluded. Fasting TSH, free thyroxine (FT4), insulin, glucose, and the level of insulin resistance, estimated by the homeostasis model assessment for insulin resistance (HOMA-IR) were measured. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Results: TSH levels were associated with total cholesterol, LDL-cholesterol, triglycerides and diastolic blood pressure. Using a multiple linear regression analysis, LDL-cholesterol, and triglycerides levels were identified as independently associated with TSH. Multivariate logistic regression analysis determined that TSH levels strongly contributed to MetS. Compared with the lower most quartile (TSH, 0.3-1.44 mIU/L), the adjusted odds ratio for MetS was 1.95 in the upper most quartile (TSH, 2.48-4.00 mIU/L). The prevalence of MetS increased as the TSH quartile showed a gradual increase. Conclusion: We found a close relationship between TSH and MetS in euthyroid postmenopausal women. Therefore, more attention should be focused on postmenopausal women with high normal TSH levels for the management of cardiovascular disease.",
keywords = "Euthyroid, Metabolic syndrome, Postmenopause, Thyroid stimulating hormone",
author = "Hyun-Tae Park and Geum-Joon Cho and Ahn, {Ki Hoon} and Jung-Ho Shin and Hong, {Soon Cheol} and Tak Kim and Hur, {Jun Young} and Kim, {Young Tae} and Lee, {Kyu Wan} and Kim, {Sun Haeng}",
year = "2009",
month = "3",
day = "20",
doi = "10.1016/j.maturitas.2009.01.007",
language = "English",
volume = "62",
pages = "301--305",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women

AU - Park, Hyun-Tae

AU - Cho, Geum-Joon

AU - Ahn, Ki Hoon

AU - Shin, Jung-Ho

AU - Hong, Soon Cheol

AU - Kim, Tak

AU - Hur, Jun Young

AU - Kim, Young Tae

AU - Lee, Kyu Wan

AU - Kim, Sun Haeng

PY - 2009/3/20

Y1 - 2009/3/20

N2 - Objectives: The aim of this study was to investigate the relationship between thyroid stimulating hormone (TSH) and metabolic syndrome (MetS) in euthyroid postmenopausal women. Methods: We conducted a cross-sectional study of 2205 Korean postmenopausal women. Subjects who were not euthyroid were excluded. Fasting TSH, free thyroxine (FT4), insulin, glucose, and the level of insulin resistance, estimated by the homeostasis model assessment for insulin resistance (HOMA-IR) were measured. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Results: TSH levels were associated with total cholesterol, LDL-cholesterol, triglycerides and diastolic blood pressure. Using a multiple linear regression analysis, LDL-cholesterol, and triglycerides levels were identified as independently associated with TSH. Multivariate logistic regression analysis determined that TSH levels strongly contributed to MetS. Compared with the lower most quartile (TSH, 0.3-1.44 mIU/L), the adjusted odds ratio for MetS was 1.95 in the upper most quartile (TSH, 2.48-4.00 mIU/L). The prevalence of MetS increased as the TSH quartile showed a gradual increase. Conclusion: We found a close relationship between TSH and MetS in euthyroid postmenopausal women. Therefore, more attention should be focused on postmenopausal women with high normal TSH levels for the management of cardiovascular disease.

AB - Objectives: The aim of this study was to investigate the relationship between thyroid stimulating hormone (TSH) and metabolic syndrome (MetS) in euthyroid postmenopausal women. Methods: We conducted a cross-sectional study of 2205 Korean postmenopausal women. Subjects who were not euthyroid were excluded. Fasting TSH, free thyroxine (FT4), insulin, glucose, and the level of insulin resistance, estimated by the homeostasis model assessment for insulin resistance (HOMA-IR) were measured. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Results: TSH levels were associated with total cholesterol, LDL-cholesterol, triglycerides and diastolic blood pressure. Using a multiple linear regression analysis, LDL-cholesterol, and triglycerides levels were identified as independently associated with TSH. Multivariate logistic regression analysis determined that TSH levels strongly contributed to MetS. Compared with the lower most quartile (TSH, 0.3-1.44 mIU/L), the adjusted odds ratio for MetS was 1.95 in the upper most quartile (TSH, 2.48-4.00 mIU/L). The prevalence of MetS increased as the TSH quartile showed a gradual increase. Conclusion: We found a close relationship between TSH and MetS in euthyroid postmenopausal women. Therefore, more attention should be focused on postmenopausal women with high normal TSH levels for the management of cardiovascular disease.

KW - Euthyroid

KW - Metabolic syndrome

KW - Postmenopause

KW - Thyroid stimulating hormone

UR - http://www.scopus.com/inward/record.url?scp=63049085136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049085136&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2009.01.007

DO - 10.1016/j.maturitas.2009.01.007

M3 - Article

C2 - 19250778

AN - SCOPUS:63049085136

VL - 62

SP - 301

EP - 305

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 3

ER -